The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...

The good news? There isn’t a metformin diet plan you need to follow. The bad news? There isn’t a metformin diet plan to ...

Who knew weight loss involved so much math? Counting calories can be a useful tool to help you lose weight and keep it off. But you don’t have to count calories to lose weight — and there are even ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic ...

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

The author recommends consulting a doctor before taking new supplements in conjunction with weight loss medications ... aim for everyday with a TDEE calculator. GLP-1's are a category of ...

A MUM has revealed the surprising side benefit of using skinny jabs – and it’s proved just as life-changing as shedding 7st.

Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $-0.24. Operator: Welcome to the Rani ...

Ozempic (semaglutide) and Victoza (liraglutide ... Ozempic and Victoza are not approved for weight loss or weight management. However, some people using Ozempic and Victoza in studies did lose ...

With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...